Gill Baird has completed the acquisition of St Ellen's Hospital in Livingston, along with its adjoining expansion site, in an undisclosed seven-figure deal. The transaction cements her ownership of one of Scotland's most established independent private hospitals and sets up a credible platform for further growth in a sector where demand is not going quietly away.
The timing matters. Scotland's private healthcare market is under sustained pressure from NHS waiting list backlogs that show little sign of clearing quickly. According to Public Health Scotland's latest figures, over 790,000 patients were waiting for a first outpatient appointment as of early 2024. That backlog is not just a health crisis; it is a commercial environment in which well-run independent hospitals have real structural tailwind behind them.
Baird brings credibility to the acquisition. Her recognition as CEO of the Year at the Scottish Business Awards in June 2025 is not a vanity metric; it reflects a track record of operational discipline in a sector where regulation, staffing, and patient outcomes leave no room for sloppy management. Acquiring the expansion site alongside the main hospital building is the telling detail here. This is not a consolidation play. It is a growth plan with bricks and mortar already in place to execute it.
For Scotland's broader SME and entrepreneurial ecosystem, the deal is a useful reference point. Seven-figure acquisitions in healthcare are not the exclusive territory of private equity firms and London-based consolidators. Scottish Enterprise and Business Gateway both maintain dedicated support for ambitious owner-operators looking to scale through acquisition, including access to strategic growth funding and introductions to commercial lenders with experience in regulated-sector deals. The Scottish EDGE fund, while more typically associated with early-stage ventures, has also supported founders in healthcare services at various stages of growth.
The independent private hospital sector in Scotland remains relatively fragmented compared to England, where chains such as Spire and Nuffield dominate. That fragmentation creates genuine opportunity for founder-led operators who understand local markets and can move faster than institutional owners. Baird's acquisition of an expansion site alongside the operating hospital suggests she is thinking several moves ahead. Livingston's position as a commuter hub between Edinburgh and Glasgow, with a large working-age population and good transport links, is not an accident as a location choice.